241 related articles for article (PubMed ID: 26198696)
1. Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.
Kadra G; Stewart R; Shetty H; Jackson RG; Greenwood MA; Roberts A; Chang CK; MacCabe JH; Hayes RD
BMC Psychiatry; 2015 Jul; 15():166. PubMed ID: 26198696
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic polypharmacy and adverse drug reactions among adults in a London mental health service, 2008-2018.
Yang JC; Thygesen JH; Werbeloff N; Hayes JF; Osborn DPJ
Psychol Med; 2023 Jul; 53(9):4220-4227. PubMed ID: 35485715
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country.
Armstrong KS; Temmingh H
Braz J Psychiatry; 2017; 39(4):293-301. PubMed ID: 28177063
[TBL] [Abstract][Full Text] [Related]
4. Incident users of antipsychotics: who are they and how do they fare?
Baandrup L; Kruse M
Soc Psychiatry Psychiatr Epidemiol; 2016 Apr; 51(4):505-12. PubMed ID: 26409887
[TBL] [Abstract][Full Text] [Related]
5. Predictors of long-term (≥6months) antipsychotic polypharmacy prescribing in secondary mental healthcare.
Kadra G; Stewart R; Shetty H; Downs J; MacCabe JH; Taylor D; Hayes RD
Schizophr Res; 2016 Jul; 174(1-3):106-112. PubMed ID: 27091655
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Concurrent Oral and Long-Acting Injectable Antipsychotic Prescribing at the Minneapolis Veterans Affairs Health Care System.
Dimitropoulos E; Drogemuller L; Wong K
J Clin Psychopharmacol; 2017 Oct; 37(5):605-608. PubMed ID: 28816923
[TBL] [Abstract][Full Text] [Related]
7. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic Polypharmacy Among Patients With Schizophrenia in Africa: A Systematic Review and Meta-Analysis.
Ayenew W; Asmamaw G; Bitew T
Int J Neuropsychopharmacol; 2021 Dec; 24(12):956-964. PubMed ID: 34245271
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment.
Toteja N; Gallego JA; Saito E; Gerhard T; Winterstein A; Olfson M; Correll CU
Int J Neuropsychopharmacol; 2014 Jul; 17(7):1095-105. PubMed ID: 23673334
[TBL] [Abstract][Full Text] [Related]
11. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
[No Abstract] [Full Text] [Related]
12. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing.
Burness C; Corbet C; Beyene K; Webby C; Nankivell C; Cabasag P; Hari K; Fraser A; Gray S; Harrison J; Chan AHY
Psychiatry Res; 2021 Aug; 302():113996. PubMed ID: 34126462
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic prescribing quality and ethnicity: a study of hospitalized patients in south east London.
Connolly A; Rogers P; Taylor D
J Psychopharmacol; 2007 Mar; 21(2):191-7. PubMed ID: 17329299
[TBL] [Abstract][Full Text] [Related]
15. Unraveling ethnic disparities in antipsychotic prescribing among patients with psychosis: A retrospective cohort study based on electronic clinical records.
Wang T; Codling D; Bhugra D; Msosa Y; Broadbent M; Patel R; Roberts A; McGuire P; Stewart R; Dobson R; Harland R
Schizophr Res; 2023 Oct; 260():168-179. PubMed ID: 37669576
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease treatment among patients with severe mental illness: a data linkage study between primary and secondary care.
Woodhead C; Ashworth M; Broadbent M; Callard F; Hotopf M; Schofield P; Soncul M; Stewart RJ; Henderson MJ
Br J Gen Pract; 2016 Jun; 66(647):e374-81. PubMed ID: 27114210
[TBL] [Abstract][Full Text] [Related]
17. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.
Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L
Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic Polypharmacy and High-Dose Antipsychotics in Involuntary Patients: a Seven-Year Audit of Discharge Prescriptions in an Acute Care Unit.
Martinho S; Poças A; Simões M; Laureano C
Psychiatr Q; 2021 Mar; 92(1):1-14. PubMed ID: 32430698
[TBL] [Abstract][Full Text] [Related]
20. Study on the prescribing patterns of antipsychotic medication in a rural England Community Mental Health Team.
Seshadri M; Elsemary A; Thalitaya MD; Chikodzore L; Nagalingam P
Psychiatr Danub; 2017 Sep; 29(Suppl 3):524-529. PubMed ID: 28953820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
